Waverley Pharma Financial Overview
Waverley Pharma's market cap is currently C$810.00K. The company's EPS TTM is C$-0.004; its P/E ratio is -2.21; Waverley Pharma is scheduled to report earnings on November 26, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
